Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Plos Neglected Tropical Diseases
|
August 14, 2018
Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
Paul J Converse, Deepak V Almeida, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2024
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis
Si-Yang Li, Sandeep Tyagi, Heena Soni, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 mice
Somnath Shee, Meixiang Huang, Meghraj Singh Baghel, et al.
Nature Communications
|
August 24, 2024
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen
Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, et al.
Plos One
|
May 3, 2018
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis
Stéphane Leung-Theung-Long, Charles-Antoine Coupet, Marie Gouanvic, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis
Lourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado, et al.
Plos One
|
April 28, 2010
The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models
Paul J Converse, Kathleen D Eisenach, Sue A Theus, et al.
Nature Communications
|
January 18, 2025
The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis
Andreas Römpp, Axel Treu, Julia Kokesch-Himmelreich, et al.
Antimicrobial Agents and Chemotherapy
|
May 9, 2018
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis
Nicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, et al.
Science (New York, N.Y.)
|
June 6, 2015
Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins
Angela Kling, Peer Lukat, Deepak V Almeida, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Plos Neglected Tropical Diseases
|
August 14, 2018
Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
Paul J Converse, Deepak V Almeida, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2024
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis
Si-Yang Li, Sandeep Tyagi, Heena Soni, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 mice
Somnath Shee, Meixiang Huang, Meghraj Singh Baghel, et al.
Nature Communications
|
August 24, 2024
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen
Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, et al.
Plos One
|
May 3, 2018
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis
Stéphane Leung-Theung-Long, Charles-Antoine Coupet, Marie Gouanvic, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis
Lourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado, et al.
Plos One
|
April 28, 2010
The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models
Paul J Converse, Kathleen D Eisenach, Sue A Theus, et al.
Nature Communications
|
January 18, 2025
The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis
Andreas Römpp, Axel Treu, Julia Kokesch-Himmelreich, et al.
Antimicrobial Agents and Chemotherapy
|
May 9, 2018
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis
Nicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, et al.
Science (New York, N.Y.)
|
June 6, 2015
Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins
Angela Kling, Peer Lukat, Deepak V Almeida, et al.
Page
of 8